BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33982372)

  • 1. Optical genome mapping, a promising alternative to gold standard cytogenetic approaches in a series of acute lymphoblastic leukemias.
    Lestringant V; Duployez N; Penther D; Luquet I; Derrieux C; Lutun A; Preudhomme C; West M; Ouled-Haddou H; Devoldere C; Marolleau JP; Garçon L; Jedraszak G; Ferret Y
    Genes Chromosomes Cancer; 2021 Oct; 60(10):657-667. PubMed ID: 33982372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical genome mapping enables constitutional chromosomal aberration detection.
    Mantere T; Neveling K; Pebrel-Richard C; Benoist M; van der Zande G; Kater-Baats E; Baatout I; van Beek R; Yammine T; Oorsprong M; Hsoumi F; Olde-Weghuis D; Majdali W; Vermeulen S; Pauper M; Lebbar A; Stevens-Kroef M; Sanlaville D; Dupont JM; Smeets D; Hoischen A; Schluth-Bolard C; El Khattabi L
    Am J Hum Genet; 2021 Aug; 108(8):1409-1422. PubMed ID: 34237280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical Genome Mapping Reveals Novel Structural Variants in Lymphoblastic Lymphoma.
    Xu H; Gao H; Wang C; Cheng X; Li Z; Lei C; Huang X; Li W; Yue Z; Tian S; Zhao X; Xue T; Xing T; Li J; Wang Y; Duan Y; Wang T; Zhang R
    J Pediatr Hematol Oncol; 2024 Jan; 46(1):e71-e82. PubMed ID: 38018972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical genome mapping in acute myeloid leukemia: a multicenter evaluation.
    Levy B; Baughn LB; Akkari Y; Chartrand S; LaBarge B; Claxton D; Lennon PA; Cujar C; Kolhe R; Kroeger K; Pitel B; Sahajpal N; Sathanoori M; Vlad G; Zhang L; Fang M; Kanagal-Shamanna R; Broach JR
    Blood Adv; 2023 Apr; 7(7):1297-1307. PubMed ID: 36417763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optical Genome Mapping as a Tool to Unveil New Molecular Findings in Hematological Patients with Complex Chromosomal Rearrangements.
    Coccaro N; Zagaria A; Anelli L; Tarantini F; Tota G; Conserva MR; Cumbo C; Parciante E; Redavid I; Ingravallo G; Minervini CF; Minervini A; Specchia G; Musto P; Albano F
    Genes (Basel); 2023 Dec; 14(12):. PubMed ID: 38137002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Optical Genome Mapping to Detect Structural Variants in Neuroblastoma.
    Barford RG; Whittle E; Weir L; Fong FC; Goodman A; Hartley HE; Allinson LM; Tweddle DA
    Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Optical Genome Mapping With Conventional Diagnostic Methods for Structural Variant Detection in Hematologic Malignancies.
    Shim Y; Koo YK; Shin S; Lee ST; Lee KA; Choi JR
    Ann Lab Med; 2024 Jul; 44(4):324-334. PubMed ID: 38433573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optical genome mapping reveals balanced and unbalanced genetic changes associated with tumor-forming potential in an early-stage prostate cancer epithelial subline (M2205).
    Paulraj P; Barrie E; Jackson-Cook C
    Mol Genet Genomic Med; 2024 Jan; 12(1):e2307. PubMed ID: 37902189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical Genome Mapping for Comprehensive Cytogenetic Analysis of Soft-Tissue and Bone Tumors for Diagnostic Purposes.
    Baelen J; Dewaele B; Debiec-Rychter M; Sciot R; Schöffski P; Hompes D; Sinnaeve F; Wafa H; Vanden Bempt I
    J Mol Diagn; 2024 May; 26(5):374-386. PubMed ID: 38395407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical genome mapping for prenatal diagnosis: A prospective study.
    Goumy C; Guy Ouedraogo Z; Soler G; Eymard-Pierre E; Laurichesse H; Delabaere A; Gallot D; Bouchet P; Perthus I; Pebrel-Richard C; Gouas L; Salaun G; Salse J; Véronèse L; Tchirkov A
    Clin Chim Acta; 2023 Nov; 551():117594. PubMed ID: 37832906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optical Genome Mapping Reveals the Complex Genetic Landscape of Myeloma.
    Giguère A; Raymond-Bouchard I; Collin V; Claveau JS; Hébert J; LeBlanc R
    Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optical Genome Mapping for Chromosomal Aberrations Detection-False-Negative Results and Contributing Factors.
    Xu Y; Zhang Q; Wang Y; Zhou R; Ji X; Meng L; Luo C; Liu A; Jiao J; Chen H; Zeng H; Hu P; Xu Z
    Diagnostics (Basel); 2024 Jan; 14(2):. PubMed ID: 38248042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multisite Assessment of Optical Genome Mapping for Analysis of Structural Variants in Constitutional Postnatal Cases.
    Iqbal MA; Broeckel U; Levy B; Skinner S; Sahajpal NS; Rodriguez V; Stence A; Awayda K; Scharer G; Skinner C; Stevenson R; Bossler A; Nagy PL; Kolhe R
    J Mol Diagn; 2023 Mar; 25(3):175-188. PubMed ID: 36828597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical Genome Mapping for a Patient with a Congenital Disorder and Chromosomal Translocation.
    Ogiwara Y; Hattori A; Ikegawa K; Hasegawa Y; Kuroki Y; Miyado M; Fukami M
    Cytogenet Genome Res; 2022; 162(11-12):617-624. PubMed ID: 37231804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cas9-directed long-read sequencing to resolve optical genome mapping findings in leukemia diagnostics.
    de Boer EN; Vroom V; Scheper AJ; Johansson LF; Bosscher L; Rietema N; Commandeur-Jan SZ; Knoers NVAM; Sikkema-Raddatz B; van den Berg E; van Diemen CC
    Sci Rep; 2024 Apr; 14(1):8508. PubMed ID: 38605095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical Genome Mapping in Routine Human Genetic Diagnostics-Its Advantages and Limitations.
    Dremsek P; Schwarz T; Weil B; Malashka A; Laccone F; Neesen J
    Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetics in the management of B-cell acute lymphoblastic leukemia: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
    Tueur G; Quessada J; De Bie J; Cuccuini W; Toujani S; Lefebvre C; Luquet I; Michaux L; Lafage-Pochitaloff M
    Curr Res Transl Med; 2023; 71(4):103434. PubMed ID: 38064905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analytic Validation of Optical Genome Mapping in Hematological Malignancies.
    Pang AWC; Kosco K; Sahajpal NS; Sridhar A; Hauenstein J; Clifford B; Estabrook J; Chitsazan AD; Sahoo T; Iqbal A; Kolhe R; Raca G; Hastie AR; Chaubey A
    Biomedicines; 2023 Dec; 11(12):. PubMed ID: 38137484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of cytogenetic abnormalities in multiple myeloma by using optical genome mapping].
    Wang YF; Zhang ZH; Wang H; Xi LY; Dong F; Jing HM
    Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):303-307. PubMed ID: 38716605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of Optical Genome Mapping from Placental and Umbilical Cord Sampled after Spontaneous or Therapeutic Pregnancy Termination.
    Goumy C; Ouedraogo ZG; Bellemonte E; Eymard-Pierre E; Soler G; Perthus I; Pebrel-Richard C; Gouas L; Salaun G; Véronèse L; Laurichesse H; Darcha C; Tchirkov A
    Diagnostics (Basel); 2023 Nov; 13(23):. PubMed ID: 38066817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.